[1] [1] CHAI Q, LU Z, LIU Z, et al. Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis[J]. Commun Biol, 2020, 3(1): 604.

[2] [2] CONRADIE F, BAGDASARYAN T R, BORISOV S, et al. Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis[J]. N Engl J Med, 2022, 387(9): 810-823.

[3] [3] ODA N, UEHARA S, NAKANO T, et al. Subjective contrast of pulmonary tissues in CsI-FPD chest radiography using model phantom by Monte Carlo simulation[J]. Nihon Hoshasen Gijutsu Gakkai Zasshi, 2023, 79(2): 128-141.

[4] [4] LEE H N, KIM J I, KIM Y H. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis[J]. PLoS One, 2021, 16(5): e0250616.

[5] [5] LI F, ZHANG Y, WANG Z H, et al. SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Epigenetics, 2023, 15(1): 79.

[6] [6] HAMILTON J A. GM-CSF in inflammation[J]. J Exp Med, 2020, 217(1): e20190945.

[10] [10] NATARAJAN A, BEENA P M, DEVNIKAR A V, et al. A systemic review on tuberculosis[J]. Indian J Tuberc, 2020, 67(3): 295-311.

[11] [11] PREDA M, TNASE B C, ZOB D L, et al. The bidirectional relationship between pulmonary tuberculosis and lung cancer[J]. Int J Environ Res Public Health, 2023, 20(2): 1282.

[13] [13] JIA H, ZHANG L, WANG B. The value of combination analysis of tumor biomarkers for early differentiating diagnosis of lung cancer and pulmonary tuberculosis[J]. Ann Clin Lab Sci, 2019, 49(5): 645-649.

[14] [14] MARTINI K, LOUBET A, BANKIER A, et al. Nodular reverse halo sign in active pulmonary tuberculosis: a rare CT feature?[J]. Diagn Interv Imaging, 2020, 101(5): 281-287.

[17] [17] LOCKWOOD K C, LEAR T B, RAJBHANDARI S, et al. KI-AA0317 regulates SOCS1 stability to ameliorate colonic inflammation[J]. FEBS J, 2023, 290(15): 3802-3811.

[18] [18] COLLISON A M, SOKULSKY L A, KEPREOTES E, et al. miR-122 promotes virus-induced lung disease by targeting SOCS1[J]. JCI Insight, 2021, 6(7): e127933.

[20] [20] ROY T, SETH A, SHAFI H, et al. Transcriptional regulation of suppressors of cytokine signaling during infection withMycobacteriumtuberculosis in human THP-1-derived macrophages and in mice[J]. Microbes Infect, 2024, 26(3): 105282.

[21] [21] KUMAR A, TAGHI KHANI A, SANCHEZ ORTIZ A, et al. GM-CSF: a double-edged sword in cancer immunotherapy[J]. Front Immunol, 2022, 13: 901277.

[22] [22] MOREIRA-TEIXEIRA L, STIMPSON P J, STAVROPOULOS E, et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis[J]. Nat Commun, 2020, 11(1): 5566.

[25] [25] ARBUS A, SCHMIDIGER S, KAMMLLER M, et al. Extracellular matrix-induced GM-CSF and hypoxia promote immune control ofMycobacterium tuberculosisin humanin vitrogranulomas[J]. Front Immunol, 2021, 12: 727508.